Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 44-52 |
Journal | British journal of cancer |
Volume | 105 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2011 |
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy
C.R. Garrett, L.L. Siu, A. El-Khoueiry, J. Buter, C.M. Rocha-Lima, J. Marshall, P. LoRusso, P. Major, J. Chemidlin, O. Mokliatchouk, L. Velasquez, W. Hayes, D. Feltquate, S. Syed, S. Ford, G. Kollia, S. Galbraith, D.S.A. Nuyten
Research output: Contribution to journal › Article › Academic › peer-review
30
Citations
(Scopus)